Articles by Stephanie Sutton - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Stephanie Sutton
« Previous
123456789101112
Next »

EMA Investigates Roche for Deficiencies in Safety Reporting

Jun 28, 2012
By: Stephanie Sutton

The European Medicines Agency has launched an investigation into Roche after an inspection found that thousands of potential safety reports, including 15161 deaths, connected to Roche medicines had not been evaluated to determine whether they should be reported to regulators as adverse drug reactions.

EMA Finalizes Pharmacovigilance Guidelines

Jun 28, 2012
By: Stephanie Sutton

The European Medicines Agency has published its first set of finalized guidelines concerning good pharmacovigilance practices.

Merck Serono Announces Final Restructuring Plan

Jun 21, 2012
By: Stephanie Sutton

Merck Serono has revealed its final "final efficiency program" for operations in Switzerland, which includes confirmation of the closure of sites in Geneva and Coinsins and their associated job cuts.

EFPIA Calls for Urgent Action on German Pricing

Jun 14, 2012
By: Stephanie Sutton

The European Federation of Pharmaceutical Industries and Associations has called for the German government to take "urgent action" regarding its pricing system, which is perceived as hindering the market entry of new, innovative medicines in the country.

Dr. Reddy's and Merck Serono Team Up on Biosimilars

Jun 7, 2012
By: Stephanie Sutton

Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, have partnered to codevelop a portfolio of biosimilar compounds in oncology.

Cheap versus Expensive

UK chooses to use off-label drug indication to cut healthcare costs. Will others follow suit?
Jun 2, 2012
By: Stephanie Sutton

UK chooses to use off-label drug indication to cut healthcare costs. Will others follow suit?

News

Jun 1, 2012
By: Stephanie Sutton

Pharma Aid for Developing World

Antibiotic Resistance Program Launched in Europe

May 31, 2012
By: Stephanie Sutton

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the launch of a EUR 223.7-million ($276.5 million) program to tackle antimicrobial resistance and speed up the development of new antibiotics.

UK Condemns Parallel Trade

May 24, 2012
By: Stephanie Sutton

A recent report from the UK's All Party Pharmacy Group has attributed shortages of prescription medicines in the UK to parallel trade and is calling for urgent action.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here